{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:52:11Z","timestamp":1761058331061},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.diabres.2005.06.005","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T11:27:24Z","timestamp":1125055644000},"page":"119-123","source":"Crossref","is-referenced-by-count":7,"title":["Serum lipoprotein (a) levels in patients with diabetic foot lesions"],"prefix":"10.1016","volume":"71","author":[{"given":"K\u00fcr\u015fad","family":"\u00dcnl\u00fch\u0131zarc\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahattin","family":"Muhtaro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eevki","family":"Kabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahrettin","family":"Kele\u015ftimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2005.06.005_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-117-2-97","article-title":"Risk factors for amputation in patients with diabetes mellitus","volume":"117","author":"Reiber","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib2","first-page":"519","article-title":"Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid Spain","volume":"23","author":"Calle-Pascual","year":"1997","journal-title":"Diab. Metab."},{"key":"10.1016\/j.diabres.2005.06.005_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","article-title":"Lower-extremity amputation in diabetes","volume":"22","author":"Adler","year":"1999","journal-title":"Diab. Care"},{"key":"10.1016\/j.diabres.2005.06.005_bib4","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/S0021-9258(18)32663-2","article-title":"Human plasma lipoprotein (a). Structural properties","volume":"258","author":"Gaubatz","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.diabres.2005.06.005_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein (a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2005.06.005_bib6","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patient s with familial hypercholestterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.STR.17.5.942","article-title":"Lipoprotein (a) as a strong indicator for cerebrovascular disease","volume":"17","author":"Zenker","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.diabres.2005.06.005_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archinte.154.7.801","article-title":"Lp (a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men","volume":"154","author":"Valentine","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/107110078800900301","article-title":"Treatment of diabetic foot infections: Wagner classification, therapy and outcome","volume":"9","author":"Calhoun","year":"1988","journal-title":"Foot Ankle"},{"key":"10.1016\/j.diabres.2005.06.005_bib10","first-page":"549","article-title":"Estimation of LDL cholesterol based on the Friedewald formula and on Apo B levels","volume":"33","author":"Bairaktari","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.diabres.2005.06.005_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/clinchem\/36.1.20","article-title":"Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age","volume":"36","author":"Sandkamp","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.diabres.2005.06.005_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(81)90103-9","article-title":"Lipoprotein Lp (a) and the risk for myocardial infarction","volume":"38","author":"Kostner","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2005.06.005_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/ejvs.2001.1431","article-title":"Lipoprotein (a) level and mortality in patients with critical lower limb ischemia","volume":"22","author":"Cheng","year":"2001","journal-title":"Eur. J. Endovasc. Surg."},{"key":"10.1016\/j.diabres.2005.06.005_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0009-9120(94)90049-3","article-title":"Structure and possible biological roles of Lp (a)","volume":"27","author":"Karmansky","year":"1994","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.diabres.2005.06.005_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1442-200x.2001.01387.x","article-title":"Impact of glycemic control on serum lipoprotein (a) in Arab children with type 1 diabetes","volume":"43","author":"Alsaeid","year":"2001","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.diabres.2005.06.005_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7326\/0003-4819-117-1-42","article-title":"Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control","volume":"117","author":"Ramirez","year":"1992","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.263.1.35b","article-title":"Increased serum levels of lipoprotein (a) in diabetes mellitus and their reduction with glycemic control","volume":"263","author":"Bruckert","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2005.06.005_bib18","first-page":"307","article-title":"Improved metabolic control does not change plasma lipoprotein (a) levels in adolescent with type 1 diabetes mellitus","volume":"29","author":"Torres-Tamayo","year":"1998","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.diabres.2005.06.005_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1046\/j.1464-5491.1999.00183.x","article-title":"The effect of long-term glycaemic control on serum lipoprotein (a) levels in patients with Type 2 diabetes mellitus","volume":"16","author":"Song","year":"1999","journal-title":"Diab. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.CIR.74.4.758","article-title":"Association of levels of lipoprotein Lp (a), plasma lipids and other lipoprotein with coronary artery disease documented by angiography","volume":"74","author":"Dahlen","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2005.06.005_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0021-9150(86)90048-1","article-title":"Lp (a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction","volume":"59","author":"Murai","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2005.06.005_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00365519850186300","article-title":"Usefulness of lipids, lipoprotein (a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery","volume":"58","author":"Lippi","year":"1998","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.diabres.2005.06.005_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diacare.22.1.93","article-title":"Peripheral atherosclerosis and serum lipoprotein (a) in diabetes","volume":"22","author":"Wollesen","year":"1999","journal-title":"Diab. Care"},{"key":"10.1016\/j.diabres.2005.06.005_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00041433-199404000-00012","article-title":"Molecular genetics of lipoprotein (a): new pieces to the puzzle","volume":"5","author":"Gaw","year":"1994","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.diabres.2005.06.005_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diacare.20.11.1738","article-title":"Insulin resistance and arteriosclerosis obliterans in patients with NIDDM","volume":"20","author":"Matsumoto","year":"1997","journal-title":"Diab. Care"},{"key":"10.1016\/j.diabres.2005.06.005_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archinte.141.9.1128","article-title":"Lipoproteins, cardiovascular disease and death. The Framingham study","volume":"141","author":"Gordon","year":"1981","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2005.06.005_bib27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","article-title":"Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience), Prospective Cardiovascular Munster Study","volume":"70","author":"Assmann","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.diabres.2005.06.005_bib28","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI114625","article-title":"Lipoprotein (a): heterogenity and biological releavance","volume":"85","author":"Scanu","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.diabres.2005.06.005_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein (a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.diabres.2005.06.005_bib30","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.152.3.610","article-title":"The prevalence and incidence of lower extremity amputation in a diabetic population","volume":"152","author":"Moss","year":"1992","journal-title":"Arch. Intern. Med."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822705002408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822705002408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T19:41:08Z","timestamp":1626464468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822705002408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0168822705002408"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2005.06.005","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}